Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients - Concepedia

Concepedia

Publication | Open Access

Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients

DOI Full Paper Access

38

Citations

45

References

2015

Year

Claire Lucas, Robert J. Harris, Alison Holcroft, Laura J. Scott, Natasha Carmell, Elizabeth S. McDonald, Fotis Polydoros, R E Clark

Hematological MalignancyOncologyDisease ProgressionMedicineMixed-phenotype Acute LeukemiaReceptor Tyrosine KinaseHematologyMyeloid NeoplasiaMalignant Blood DisorderHigh Cip2aPharmacotherapyPharmacologyRadiation OncologyHealth Sciences

References

	Year	Citations

Page 1

Page 1